News

Archive: November, 2021

Biden Administration Secures 10 Million Courses of Pfizer’s COVID-19 Oral Antiviral Medicine as Additional Tool to Reduce Hospitalizations and Save Lives
November 18, 2021 — As part of its ongoing efforts to curb the pandemic, reduce hospitalizations, and save lives, the Biden Administration has secured 10 million treatment courses of Pfizer’s promising COVID-19 oral antiviral drug, contingent on emergency use authorization (EUA) or approval from the U.S. Food and Drug Administration (FDA)... MORE

American flags against a blue sky background

JPM CBRN Medical Announces RPP in Support of Vaccine Acceleration Program
November 15, 2021 — The Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear (CBRN) Defense’s (JPEO-CBRND) Joint Project Manager for CBRN Medical (JPM CBRN Medical), in collaboration with the JPEO-CBRND’s Joint Project Lead for CBRN Defense Enabling Biotechnologies (JPL CBRND EB), and the U.S. Department of Health and Human Services’ (HHS) Biomedical Advanced Research and Development Authority (BARDA), released a request for prototype proposal (RPP) on November 10, 2021, soliciting offers for mRNA vaccine development through December 13, 2021. These offers will include mRNA vaccine design, non-clinical testing, and clinical testing against priority biological threats. ... MORE

JPEO-CBRND Team and Partners Win Five Defense Acquisition Workforce Awards
November 12, 2021 — The Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO-CBRND) celebrates its teammates and partners who collectively won five 2021 Defense Acquisition Workforce Awards for their work at the organization... MORE

Winners from the 2021 Defense Acquisition Workforce Award include LTC John Nuckols, Dr. Kevin Wingerd, JPEO-CBRND, U.S. Air Force, COVID-19 USTRANSCOM JUON TC-0003 Response, and U.S. Army, Operation Warp Speed and the JPEO-CBRND Medical Repurposing Team.

CB Defense Today with guest Dr. Jason Roos
November 9, 2021 — CB Defense Today is a quarterly recorded interview, where CBC Director, Dr. Eric L. Moore talks with other leaders across the CB Defense Enterprise. This September Dr. Moore’s guest was Joint Program Executive Officer for CBRND, Dr. Jason Roos. The two discussed the valuable partnership between CBC and JPEO for Chemical, Biological, Radiological and Nuclear Defense, pandemic preparedness in the chemical biological defense space, and improving warfighter protection and decontamination in the field based on future operating environments... MORE

Screenshot of CB Defense Today with guest Dr. Jason Roos

Newly Confirmed Assistant Secretary of Defense, Other DOD Officials Make Inaugural Visit to JPEO-CBRND
November 5, 2021 — Ms. Deborah Rosenblum, the Assistant Secretary of Defense for Nuclear, Chemical, and Biological Defense Programs (ASD(NCB)) and several other DOD officials visited the headquarters of the Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear (CBRN) Defense (JPEO-CBRND) at the Aberdeen Proving Ground - Edgewood, Md., on Monday, October 25, 2021. This was Ms. Rosenblum’s first visit to JPEO-CBRND after her Senate confirmation vote on July 29, 2021. ... MORE

DOD Awards Dynavax $22 Million for Plague Vaccine Clinical Trial
November 3, 2021 — The U.S. Department of Defense (DOD) awarded Dynavax Technologies Corporation with an agreement worth approximately $22 million over two and a half years, to execute a clinical trial combining the DOD’s recombinant plague (rF1V) vaccine with its own CpG 1018® adjuvant. Under the agreement, Dynavax will conduct a Phase II clinical trial in 2022. ... MORE

News Search

News Archive - Search by Year and Month

October 2023 (1)
September 2023 (5)
August 2023 (8)
July 2023 (2)
June 2023 (2)
May 2023 (3)
April 2023 (2)
March 2023 (1)
February 2023 (1)
January 2023 (1)
December 2022 (4)
November 2022 (1)
October 2022 (3)
September 2022 (5)
August 2022 (3)
July 2022 (3)
June 2022 (1)
May 2022 (1)
March 2022 (2)
February 2022 (2)
January 2022 (5)
December 2021 (1)
November 2021 (6)
October 2021 (2)
September 2021 (1)
July 2021 (1)
June 2021 (1)
May 2021 (8)
April 2021 (6)
March 2021 (2)
February 2021 (5)
January 2021 (4)
December 2020 (3)
November 2020 (1)
August 2020 (1)
July 2020 (3)
May 2020 (1)
April 2020 (1)
March 2020 (4)
February 2020 (1)
December 2019 (2)
November 2019 (2)
October 2019 (2)
September 2019 (2)
March 2019 (1)
January 2019 (2)
December 2018 (1)
October 2018 (1)
July 2018 (1)
April 2018 (1)
February 2018 (1)
December 2017 (1)
November 2017 (2)
September 2017 (1)
June 2017 (2)
January 2017 (3)
December 2016 (1)

JPEO-CBRND Press Kit

Download our press kit, which includes helpful documents to better understand our work, such as – Command Brief, Chemical Biological Defense Program's Enterprise strategy, the JPEO-CBRND's Capabilities Catalog, Leadership Biographies, COVID-19 fact sheets, and contracting overview documents.

JPEO-CBRND Public Affairs Office

The JPEO-CBRND Public Affairs Office coordinates and responds to all public affairs and media relations needs on behalf of the JPEO-CBRND. To request a speaker, subject matter expert, or for other interview or request for comment please email our Public Affairs Office email below.